Literature DB >> 28404671

Update on Antimicrobial Resistance in Clostridium difficile: Resistance Mechanisms and Antimicrobial Susceptibility Testing.

Zhong Peng1,2, Dazhi Jin3,4, Hyeun Bum Kim5, Charles W Stratton6, Bin Wu2, Yi-Wei Tang7,8, Xingmin Sun9,10.   

Abstract

Oral antibiotics such as metronidazole, vancomycin and fidaxomicin are therapies of choice for Clostridium difficile infection. Several important mechanisms for C. difficile antibiotic resistance have been described, including the acquisition of antibiotic resistance genes via the transfer of mobile genetic elements, selective pressure in vivo resulting in gene mutations, altered expression of redox-active proteins, iron metabolism, and DNA repair, as well as via biofilm formation. This update summarizes new information published since 2010 on phenotypic and genotypic resistance mechanisms in C. difficile and addresses susceptibility test methods and other strategies to counter antibiotic resistance of C. difficile.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Clostridium difficile; antibiotics; biofilm; drug resistance; testing

Mesh:

Substances:

Year:  2017        PMID: 28404671      PMCID: PMC5483901          DOI: 10.1128/JCM.02250-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  67 in total

Review 1.  Update on Clostridium difficile infection.

Authors:  Caoilfhionn O'Donoghue; Lorraine Kyne
Journal:  Curr Opin Gastroenterol       Date:  2011-01       Impact factor: 3.287

2.  Antibiotic resistance patterns and PCR-ribotyping of Clostridium difficile strains isolated from swine and dogs in Italy.

Authors:  Patrizia Spigaglia; Ilenia Drigo; Fabrizio Barbanti; Paola Mastrantonio; Luca Bano; Cosetta Bacchin; Cinzia Puiatti; Elena Tonon; Giacomo Berto; Fabrizio Agnoletti
Journal:  Anaerobe       Date:  2014-10-12       Impact factor: 3.331

3.  Molecular Epidemiology of Clostridium difficile Infection in Hospitalized Patients in Eastern China.

Authors:  Dazhi Jin; Yun Luo; Chen Huang; Jian Cai; Julian Ye; Yi Zheng; Liqian Wang; Peng Zhao; Anbing Liu; Weijia Fang; Xianjun Wang; Shichang Xia; Jianmin Jiang; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2016-12-14       Impact factor: 5.948

4.  Susceptibility testing of Clostridium difficile against metronidazole and vancomycin by disk diffusion and Etest.

Authors:  S S Wong; P C Woo; W K Luk; K Y Yuen
Journal:  Diagn Microbiol Infect Dis       Date:  1999-05       Impact factor: 2.803

5.  Antimicrobial resistance, toxinotype, and genotypic profiling of Clostridium difficile isolates of swine origin.

Authors:  Pamela R Fry; Siddhartha Thakur; Melanie Abley; Wondwossen A Gebreyes
Journal:  J Clin Microbiol       Date:  2012-04-18       Impact factor: 5.948

6.  Association between PCR ribotypes and antimicrobial susceptibility among Clostridium difficile isolates from healthcare-associated infections in South Korea.

Authors:  Jieun Kim; Jung Oak Kang; Hyunjoo Pai; Tae Yeal Choi
Journal:  Int J Antimicrob Agents       Date:  2012-05-11       Impact factor: 5.283

7.  Rifaximin disc diffusion test for in vitro susceptibility testing of Clostridium difficile.

Authors:  Steliana Huhulescu; Ulrich Sagel; Anita Fiedler; Verena Pecavar; Marion Blaschitz; Guenther Wewalka; Franz Allerberger; Alexander Indra
Journal:  J Med Microbiol       Date:  2011-02-03       Impact factor: 2.472

8.  Antimicrobial susceptibility profiles of human and piglet Clostridium difficile PCR-ribotype 078.

Authors:  Elisabeth C Keessen; Marjolein Pm Hensgens; Patrizia Spigaglia; Fabrizio Barbanti; Ingrid Mjg Sanders; Ed J Kuijper; Len Ja Lipman
Journal:  Antimicrob Resist Infect Control       Date:  2013-04-08       Impact factor: 4.887

9.  Antimicrobial susceptibility of clostridium difficile clinical isolates in iran.

Authors:  Mehdi Goudarzi; Hossein Goudarzi; Masoud Alebouyeh; Masoumeh Azimi Rad; Farahnaz Sadat Shayegan Mehr; Mohammad Reza Zali; Mohammad Mehdi Aslani
Journal:  Iran Red Crescent Med J       Date:  2013-08-05       Impact factor: 0.611

Review 10.  Clostridium difficile infection: a review of current and emerging therapies.

Authors:  Andrew Ofosu
Journal:  Ann Gastroenterol       Date:  2016 Apr-Jun
View more
  71 in total

1.  The prevalence of antibiotic-resistant Clostridium species in Iran: a meta-analysis.

Authors:  Farzad Khademi; Amirhossein Sahebkar
Journal:  Pathog Glob Health       Date:  2019-04-09       Impact factor: 2.894

2.  Facilely accessible quinoline derivatives as potent antibacterial agents.

Authors:  Peng Teng; Chunhui Li; Zhong Peng; Vanderschouw Anne Marie; Alekhya Nimmagadda; Ma Su; Yaqiong Li; Xingmin Sun; Jianfeng Cai
Journal:  Bioorg Med Chem       Date:  2018-05-22       Impact factor: 3.641

3.  The (p)ppGpp Synthetase RSH Mediates Stationary-Phase Onset and Antibiotic Stress Survival in Clostridioides difficile.

Authors:  Astha Pokhrel; Asia Poudel; Kory B Castro; Michael J Celestine; Adenrele Oludiran; Alden J Rinehold; Anthony M Resek; Mariam A Mhanna; Erin B Purcell
Journal:  J Bacteriol       Date:  2020-09-08       Impact factor: 3.490

4.  Examination of the Clostridioides (Clostridium) difficile VanZ ortholog, CD1240.

Authors:  Emily C Woods; Daniela Wetzel; Monjori Mukerjee; Shonna M McBride
Journal:  Anaerobe       Date:  2018-06-22       Impact factor: 3.331

Review 5.  The role of vaccines in preventing bacterial antimicrobial resistance.

Authors:  Kathrin U Jansen; Charles Knirsch; Annaliesa S Anderson
Journal:  Nat Med       Date:  2018-01-09       Impact factor: 53.440

6.  U.S.-Based National Surveillance for Fidaxomicin Susceptibility of Clostridioides difficile-Associated Diarrheal Isolates from 2013 to 2016.

Authors:  C M Thorpe; L A McDermott; M K Tran; J Chang; S G Jenkins; E J C Goldstein; R Patel; B A Forbes; S Johnson; D N Gerding; D R Snydman
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

7.  Antimicrobial Susceptibilities of Clostridium difficile Isolates from 12 Asia-Pacific Countries in 2014 and 2015.

Authors:  Tanya Lew; Papanin Putsathit; Kyung Mok Sohn; Yuan Wu; Kentaro Ouchi; Yoshikazu Ishii; Kazuhiro Tateda; Thomas V Riley; Deirdre A Collins
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

8.  Healthcare-associated infections and antimicrobial resistance in Canadian acute care hospitals, 2014-2018.

Authors:  Canadian Nosocomial Infection Surveillance
Journal:  Can Commun Dis Rep       Date:  2020-05-07

9.  Cationic Homopolymers Inhibit Spore and Vegetative Cell Growth of Clostridioides difficile.

Authors:  Joshua B Jones; Lei Liu; Leslie A Rank; Daniela Wetzel; Emily C Woods; Naomi Biok; Sarah E Anderson; Myung-Ryul Lee; Runhui Liu; Sean Huth; Brindar K Sandhu; Samuel H Gellman; Shonna M McBride
Journal:  ACS Infect Dis       Date:  2021-03-19       Impact factor: 5.084

Review 10.  Clostridioides difficile phage biology and application.

Authors:  Joshua Heuler; Louis-Charles Fortier; Xingmin Sun
Journal:  FEMS Microbiol Rev       Date:  2021-09-08       Impact factor: 16.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.